Probiotic + 5‐aminosalicylic acid (5‐ASA) (mesalazine) vs 5‐aminosalicylic acid (5‐ASA) (mesalazine)
The review found no eligible studies for this question.
- no estimate extractedStudies not reportedNo studies found
The review found no eligible studies for this question.
Any antibiotic treatment may leads to higher minor adverse events in sexual partner compared with placebo (low certainty).
It is very uncertain whether probiotics changes minor adverse events compared with 5‐aminosalicylic acid (5‐ASA) (mesalazine) (very low certainty).
It is very uncertain whether surgical thrombectomy changes minor adverse events compared with mechanical thrombectomy (very low certainty).
It is very uncertain whether mechanical thrombectomy changes minor adverse events compared with pulse spray technique (very low certainty).
It is very uncertain whether mechanical thrombectomy changes minor adverse events compared with continuous infusion (very low certainty).
It is very uncertain whether surgical thrombectomy changes minor adverse events compared with continuous infusion (very low certainty).
It is very uncertain whether continuous Infusion changes minor adverse events compared with pulse spray technique (very low certainty).
It is very uncertain whether pharmacomechanical thrombolysis (Cragg® catheter) changes minor adverse events compared with pulse spray technique (very low certainty).
It is very uncertain whether surgical thrombectomy changes minor adverse events compared with different types of endovascular interventions (very low certainty).
The review found no eligible studies for this question.
Oral hydroxychloroquine showed no clear difference in adverse events: minor compared with placebo (moderate certainty).
Oral dehydroepiandrosterone probably leads to higher adverse events: minor compared with placebo (moderate certainty).
Oral methotrexate may leads to higher adverse events: minor compared with oral chloroquine (low certainty).
Oral methotrexate showed no clear difference in adverse events: minor compared with placebo (moderate certainty).
The review found no eligible studies for this question.
The review found no eligible studies for this question.
The review found no eligible studies for this question.